ACTA1 and Hepatic fibrosis: Inhibition of EZH2 attenuates fibrogenic gene transcription in TGF-β-mediated HSC activation in in vitro and in vivo liver fibrosis murine models, reducing the expression of fibronectin, α-SMA, and collagen 1α1 [27].